• SENSEX
    NIFTY 50
Business

Aurobindo Pharma stock tumbles, investors wary as Srikakulam API plant gets USFDA warning letter

Updated : June 21, 2019 03:59 PM IST

While the warning letter does not impact the current sales from the facility, it will impact future approvals until remediation steps are complete.
An OAI status is the most severe of three certifications issued to a drug manufacturing plant after a USFDA inspection.
Aurobindo Pharma stock tumbles, investors wary as Srikakulam API plant gets USFDA warning letter
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV